Of 2,130 candidates, the European Research Council (ERC) selected 308 researchers for this year’s Consolidator Grants. Magnus Øverlie Arntzen at NMBU is 1 of only 4 awardees from Norway. He has received 2 million Euros (ca 24 million NOK) to study the properties of a unique set of microbial enzymes that may prove to be game changes for a wide range of challenges such as waste decomposition, renewable energy, and food/feed production.
News
In December 2022, two NAPI nodes were simultaneously granted institutional funding from the UiO instrument call to purchase two novel, high-end MS instruments. One at the Proteomics Core Facitlity, (Dr. Tuula Nyman - UiO-OUS) while Prof. Trine Grønhaug Halvorsen and Prof. Leon Reubsaet (Dept. of Pharmacy, UiO) received funding for the other instrument. This institutional funding is essential to maintain and further develop state-of-the art research and proteomics service at NAPI.
NAPI Project Manager Tuula Nyman will guest edit the upcoming special issue in the journal Biology, and welcomes reviews/research articles focusing on the use of proteomics to study the immune system.
The 1st Norwegian Symposium on Proteomics and Biological Mass Spectrometry took place last week at the Grand Hotel in central Oslo. The meeting was attended by nearly 100 delegates, and featured great talks and scientific discussions.
The Metaproteomics Initiative is a new global collaborative research infrastructure that includes partners from the NAPI node at NMBU, Norway.
A new collaborative study involving NAPI partner Fridtjof Lund-Johansen describes a novel approach to perform mass spectrometry-based analysis of proteins across different cell compartments.
The second NAPI bioinformatics workshop took place last week, November 26th. The workshop focused on data independent analysis (DIA) methodolgies, and was attended by researchers from all NAPI nodes.
NAPI partner Terje Johansen was included in the prestigious list of highly cited researchers 2021, as curated by Clarivate.
Cathrine Broberg Vågbø from the NAPI core facility at NTNU was involved in a collaborative study recently published in the journal Cell.
Dr Tuula Nyman is the Project Manager at NAPI. In this profile article, Tuula discusses what NAPI will bring to proteomics research in Norway, her career highlights so far, and the Swedish Royal family performing mass spectrometry experiments.
The resources page of our website now contains a full list of proteomics software available through the Norwegian Galaxy server, with a short description of how to get started.
A new collaborative study by researchers in Finland and Norway – including NAPI Project Manager Tuula Nyman – provides novel insights into how mycobacteria can escape elimination by antibiotics. These findings could have important implications for treating mycobacteria-driven diseases such as Tuberculosis.
Recent publications cover the development of 'smart samplers' for proteomic analysis of patient samples collected remotely, as well as the importance of liquid chromatography in the advancement of single cell proteomics. Both papers constitute collaborative efforts between different NAPI partners.
A new initiative that brings together metaproteomics researchers from across the world has now launched, and includes representation from NAPI.
The NAPI Kick Off Seminar received over 230 registrations and took place digitally on Friday 5th March 2021.
The NAPI core facilities at Oslo University Hospital, University of Oslo, and the Norwegian University of Life Sciences (NMBU) each received cutting-edge new mass spectrometers from Bruker Daltonics in January/February 2021.
A new study by researchers in Oslo – including staff at the NAPI Proteomics Core Facility at Oslo University Hospital – provides new insights into the curative effects of gluten-free diets in coeliac patients.
The NAPI core facility at the University of Bergen (PROBE) recently received its newest mass spectrometer; the Orbitrap Eclipse from Thermo Scientific.
Blood samples can be provided ‘on paper’ by patients at home. Recent developments by researchers from NAPI now enable blood sample processing whilst in the mail on the way to the diagnostic lab.